Alzheimer’s delaying drug for first time is a ‘potential treatment’

Brain deterioration caused by Alzheimer’s has been delayed by a drug for the first time, researchers have announced.

Scientists trialling a new treatment, called LMTX, slowed the progression of the disease over 15 months.

When the drug was the only treatment that patients took, it had a beneficial effect on key measures of Alzheimer’s — such as memory — for those with mild or moderate forms of the disease.